您所在的位置: 首页 --> 导师团队 --> 柯杨

导师基本信息

  • 姓名:柯杨
  • 性别:
  • 民族:汉族
  • 科室:遗传学研究室
  • 职称:研究员,教授
  • 专业:肿瘤学
  • E-MAIL: keyang@bjmu.edu.cn

学术论文 | 综述述评 | 奖励表彰 | 研究方向 | 科研项目

Wang Hui#, Cao Changqi#, Guo Chuanhai, He Yu, Li Fenglei, Xu Ruiping, Liu Mengfei, Liu Zhen, Pan Yaqi, Liu Fangfang, Liu Ying, Li Jingjing, Cai Hong, He Zhonghu*, Ke Yang*. An evaluation of EQ-5D-3L health utility scores using five country-specific tariffs in a rural population aged 45-69?years in Hua county, Henan province, China.,Health and quality of life outcomes,18(1):228

Li Fuxiao#, Li Xiang#, Guo Chuanhai, Xu Ruiping, Li Fenglei, Pan Yaqi, Liu Mengfei, Liu Zhen, Shi Chao, Wang Hui, Wang Minmin, Tian Hongrui, Liu Fangfang, Liu Ying, Li Jingjing, Cai Hong, Yang Li, He Zhonghu*, Ke Yang*. Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial.,Pharmacoeconomics,37(6):819-827.

Shi Chao#, Liu Mengfei#, Liu Zhen, Guo Chuanhai, Li Fenglei, Xu Ruiping, Liu Fangfang, Liu Ying, Li Jingjing, Cai Hong, He Zhonghu*, Ke Yang*. Using health insurance reimbursement data to identify incident cancer cases.,J Clin Epidemiol,114:141-149.

Tan Qin, Zhang Chaoting*, Yang Wenjun, Liu Ying, Heyilimu Palashati, Feng Dongdong, Xing Liying, Ke Yang*, Lu Zheming*. Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.,J Immunother Cancer,7(1):232.

Yuan Wenqing#, Liu Zhen#, Wang Yu, Liu Mengfei, Pan Yaqi, Lei Wanjun, Yang Haijun, Xu Ruiping, Zhang Lixin, Cai Hong, Li Jun, Ke Yang*. Clonal evolution of esophageal squamous cell carcinoma from normal mucosa to primary tumor and metastases.,Carcinogenesis,40(12):1445-1451

He Zhonghu, Ke Yang*. Precision screening for esophageal squamous cell carcinoma in China.,Chinese journal of cancer research,32(6):673-682.

Liu Mengfei#, Liu Zhen#, Liu Fangfang#, Guo Chuanhai, Xu Ruiping, Li Fenglei, Liu Anxiang, Yang Haijun, Zhang Sanshen, Shen Lin, Duan Liping, Wu Qi, Cao Changqi, Pan Yaqi, Liu Ying, Li Jingjing, Cai Hong, He Zhonghu*, Ke Yang*. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.,Clin Gastroenterol Hepatol,18(7):1626-1635 e1627

He Zhonghu#, Liu Zhen#, Liu Mengfei#, Guo Chuanhai, Xu Ruiping, Li Fenglei, Liu Anxiang, Yang Haijun, Shen Lin, Wu Qi, Duan Liping, Li Xiang, Zhang Chaoting, Pan Yaqi, Cai Hong*, Ke Yang*. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial.,Gut,68(2):198-206.

Liu Mengfei#, Zhou Ren#, Guo Chuanhai, Xu Ruiping, Liu Anxiang, Yang Haijun, Li Fenglei, Duan Liping, Shen Lin, Wu Qi, Liu Zhen, Liu Fangfang, Liu Ying, Pan Yaqi, Cai Hong, Weiss Noel S*, He Zhonghu*, Ke Yang*. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus. Gastrointest Endosc. 2020.,Gastrointest Endosc,18;S0016-5107(20)34785-4

Liu Zhen#, Guo Chuanhai#, He Yujie#, Chen Yun#, Ji Ping#, Fang Zhengyu#, Li Fenglei, Tang Yuefei, Chen Xiujian, Xiao Ping, Wang Chengwen, Yin Weihua, Guo Hai, Liu Mengfei, Pan Yaqi, Liu Fangfang, Liu Ying, He Zhonghu*, Ke Yang*. A clinical model predicting the risk of esophageal high-grade lesions in opportunistic screening: a multicenter real-world study in China,Gastrointest Endosc,91(6):1253-1260.e1253

Tian Hongrui#, Yang Wei#, Hu Yanjun#, Liu Zhen#, Chen Lei, Lei Liang, Zhang Fan, Cai Fen, Xu Huawen, Liu Mengfei, Guo Chuanhai, Chen Yun, Xiao Ping, Chen Junhui, Ji Ping, Fang Zhengyu, Liu Fangfang, Liu Ying, Pan Yaqi, Dos-Santos-Silva Isabel, He Zhonghu*, Ke Yang*. Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China.,EClinicalMedicine,20:100312.

He Z, Ke Y. Precision screening for esophageal squamous cell carcinoma in China.,China. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu,32(6): 673-82

北京大学医学部2021-2022年度桃李奖, 北京大学医学部桃李奖, 第1完成人, 北京大学医学部, 2022.9

基于临床的上消化道肿瘤预后预测研究, 课题负责人, 2021.1.1~2021.12.31, 院内基金

基于“医保”及“死因监测”大数据构建恶性肿瘤多维度监测体系, 课题负责人, 2020.11.1~2022.12.31, 横向课题——泰康

食管癌精准防治策略与大数据应用研究, 课题负责人, 2019.6.1~2025.5.31, 横向课题——北医

基于临床的食管鳞癌风险预测模型构建与验证研究, 课题负责人, 2017.1.1~2021.12.31, 深圳市政府“三名工程”

社会任职

  • 女医师协会副会长
  • 临床医学专业学位副主任
  • 《北京大学学报(医学版)》、《肿瘤研究与临床》副主编
  • Carcinogenesis、《中华肿瘤杂志》编委
  • 中华医学会副会长

学习、工作经历

  • 2014.10.1~,美国医学科学院外籍院士
  • 2004.12.31~2014.6.30,北京大学党委常委、常务副校长、医学部常务副主任
  • 2004.6.1~2004.12.31,北京大学副校长、医学部常务副主任
  • 2003.6.1~2004.6.1,北京大学医学部常务副主任
  • 2003.1.1~2005.12.31,北京大学副教务长